Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics
Notice NOT-AI-23-001 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 23, 2022 Category: Research Source Type: funding

Resources Access for Preclinical Integrated Drug Development (RAPIDD) Program (X01 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-185 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide a method for investigators to request gap filling preclinical services to academic and private institutions to assist with product development efforts and facilitate the advancement of promising therapeutics for HIV and HIV-associated co-infections (Hepatitis B, Hepatitis C and Tuberculosis). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 27, 2022 Category: Research Source Type: funding

Indiana Health Issues and Challenges Grants
Grants for programs focused on addressing health issues and challenges within Indiana. Funds must be used for improving health outcomes in one or more priority areas including tobacco use, food insecurity/obesity, lead exposure, hepatitis C, chronic disease, and public health prevention programs. Geographic coverage: Indiana -- Indiana Department of Health (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - February 23, 2022 Category: American Health Source Type: funding

West Virginia Hepatitis Academic Mentoring Partnership
An in-person and tele-mentoring partnership designed for primary care providers in rural West Virginia to link with disease experts for hepatitis C training. Geographic coverage: West Virginia -- West Virginia Rural Health Association (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - May 6, 2020 Category: American Health Source Type: funding

Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-20-019 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support novel strategies for the rational design of vaccines against hepatitis C virus (HCV), to assess the vaccines for their ability to induce protective immune responses, and to select candidates for preclinical development and clinical testing. To this end, it will be critical to advance knowledge of the structural basis for broad immunological protection, and to elucidate correlates of HCV protection by leveraging samples from existing human cohorts and vaccine studies. Thi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 24, 2020 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics
Notice NOT-AI-20-013 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 17, 2019 Category: Research Source Type: funding

Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity Limited Competition (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AA-18-008 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites a limited competing renewal of a U01 project to evaluate the cumulative and progressive effects on brain structure and cognitive/behavioral function of combined HIV infection and alcohol abuse. This project has recruited and longitudinally tracked a large cohort of individuals with HIV infection, or alcohol abuse, or the comorbid condition. As members of this cohort are growing older and living well longer due to antiretroviral medications, this project is well suited to a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 13, 2017 Category: Research Source Type: funding

Addressing Health Disparities in NIDDK Diseases (R01 - Clinical Trial Not Allowed)
Funding Opportunity PA-18-412 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites research to understand and mitigate health disparities in the development, diagnosis, and treatment of diseases of high priority to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Research is encouraged in the following high priority diseases: diabetes and other endocrine and metabolic diseases; obesity; nutrition-related disorders; hepatitis C; gallbladder disease; H. Pylori infection; complications of sickle cell disease within the NIDDK mission areas; kidney dise...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 17, 2017 Category: Research Source Type: funding

Addressing Health Disparities in NIDDK Diseases (R01 - Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites research to understand and mitigate health disparities in the development, diagnosis, and treatment of diseases of high priority to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Research is encouraged in the following high priority diseases: diabetes and other endocrine and metabolic diseases; obesity; nutrition-related disorders; hepatitis C; gallbladder disease; H. Pylori infection; complications of sickle cell disease within the NIDDK mission areas; kidney diseases; urologic diseases; metabolic, gastrointestinal, hepatic, and renal compl...
Source: NIDDK Funding Opportunities - November 17, 2017 Category: Endocrinology Source Type: funding

HIV/HCV Co-Infections in Substance Abusers (R01)
Funding Opportunity PAS-17-311 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to fill gaps in our understanding of (a) the impact of substance abuse on HIV, HIV/HCV co-infection associated disease progression, (b) the pathogenic interactions between HIV and hepatitis C virus, (c) hepatic and non-hepatic co-morbidities associated with HIV/HCV-co-infections in people with substance abuse disorders (SUDs), and (d) the effectiveness of interferon-free direct acting antiviral (DAAs) drug regimens to treat HIV/HCV co-infections in people with SUDs. This FOA is inform...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 12, 2017 Category: Research Source Type: funding

Special Projects of National Significance - Hepatitis C Treatment for People Living with HIV/AIDS - Demonstration Sites
Opportunity ID: 290885 Opportunity Number: HRSA-17-047 Opportunity Title: Special Projects of National Significance - Hepatitis C Treatment for People Living with HIV/AIDS - Demonstration SitesOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.928Eligible Applicants: State governmentsCounty governmentsCity or township governmentsNative American tribal governments (Federally recognized)Additional Information on Eligibility: Agency Code: HHS-HRSAAgency Name: Department of Health ...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding

Special Projects of National Significance - Hepatitis C Treatment for People Living with HIV/AIDS - ECTAC
Opportunity ID: 290886 Opportunity Number: HRSA-17-048 Opportunity Title: Special Projects of National Significance - Hepatitis C Treatment for People Living with HIV/AIDS - ECTACOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.928Eligible Applicants: County governmentsCity or township governmentsNative American tribal governments (Federally recognized)Additional Information on Eligibility: Agency Code: HHS-HRSAAgency Name: Department of Health and Human Servi...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding

Special Projects of National Significance - Hepatitis C Treatment for People Living with HIV/AIDS - Demonstration Sites
Opportunity ID: 290885 Opportunity Number: HRSA-17-047 Opportunity Title: Special Projects of National Significance - Hepatitis C Treatment for People Living with HIV/AIDS - Demonstration SitesOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.928Eligible Applicants: County governmentsCity or township governmentsNative American tribal governments (Federally recognized)Additional Information on Eligibility: Agency Code: HHS-HRSAAgency Name: Department of Health and Human Service...
Source: Grants.gov - December 22, 2016 Category: Research Tags: Health Source Type: funding

Special Projects of National Significance - Hepatitis C Treatment for People Living with HIV/AIDS - ECTAC
Opportunity ID: 290886 Opportunity Number: HRSA-17-048 Opportunity Title: Special Projects of National Significance - Hepatitis C Treatment for People Living with HIV/AIDS - ECTACOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.928Eligible Applicants: County governmentsCity or township governmentsNative American tribal governments (Federally recognized)Additional Information on Eligibility: Agency Code: HHS-HRSAAgency Name: Department of Health and Human Servi...
Source: Grants.gov - December 22, 2016 Category: Research Tags: Health Source Type: funding

Strengthening Surveillance in Jurisdictions with High Incidence of Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) Infections
Funding Opportunity ID: 290367 Opportunity Number: CDC-RFA-PS17-1703 Opportunity Title: Strengthening Surveillance in Jurisdictions with High Incidence of Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) InfectionsOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.270Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educatio...
Source: Grants.gov - November 30, 2016 Category: Research Tags: Health Source Type: funding